A study of the safety of alpha1-blocker silodosin in adult women

Trial Profile

A study of the safety of alpha1-blocker silodosin in adult women

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2014

At a glance

  • Drugs Silodosin (Primary)
  • Indications Lower urinary tract symptoms
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jun 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 26 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top